As the global threat of H5N1 influenza looms with outbreaks across species and continents including the U.S., three international vaccine and public health experts say it is time to fully resource and support a robust strategy to address this and future potential pandemic influenza threats, including to consider voluntary vaccination for those now at exposure risk.
Private equity activity in the pharmaceutical industry in Canada remained flat in 2024
In value terms, private equity deal activity in Canada remained flat in Q3 2024 compared with the previous quarter and as compared to Q3 2023.